Table 3 Access or gain of access to virtual global health activities
| Â | Loss of in-person GHA at own organization | Loss of in-person GHA at other organization | Gain of virtual access during pandemic through own organization | Gain of virtual access during pandemic through partner organization (keeping, leave here) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | |||||||||
HIC (n = 151) | LMIC (n = 114) | p value | HIC (n = 151) | LMIC (n = 114) | p value | HIC (n = 151) | LMIC (n = 114) | p value | HIC (n = 151) | LMIC (n = 114) | p value | |
Access to GH educational activities and resources | ||||||||||||
Professional resources supporting GHAs | 37 (24.5) | 27 (23.7) | 0.8774 | 13 (8.6) | 19 (16.7) | 0.0463* | 25 (16.6) | 27 (23.7) | 0.148 | 8 (5.3) | 19 (16.7) | 0.0025** |
GH educational materials | 34 (22.5) | 23 (20.2) | 0.6461 | 12 (8.0) | 16 (14.0) | 0.1104 | 25 (16.6) | 30 (26.3) | 0.0524 | 8 (5.3) | 18 (15.8) | 0.0045** |
GH didactic sessions | 56 (37.1) | 31 (27.2) | 0.0895 | 12 (8.0) | 16 (14.0) | 0.1104 | 52 (34.4) | 31 (27.2) | 0.2081 | 11 (7.3) | 18 (15.8) | 0.0281* |
GH simulation sessions | 33 (21.9) | 20 (17.5) | 0.3851 | 10 (6.6) | 14 (12.3) | 0.1121 | 30 (19.9) | 25 (21.9) | 0.6819 | 9 (6.0) | 15 (13.2) | 0.0432* |
Participated in the creation of GH materials | 30 (19.9) | 18 (15.8) | 0.3934 | 14 (9.3) | 12 (10.5) | 0.7339 | 27 (17.9) | 23 (20.2) | 0.6364 | 8 (5.3) | 14 (12.3) | 0.0414* |
GH experiences and electives | ||||||||||||
GH experience preparation sessions | 38 (25.2) | 25 (21.9) | 0.5401 | 13 (8.6) | 15 (13.2) | 0.233 | 26 (17.2) | 24 (21.1) | 0.4296 | 8 (5.3) | 12 (10.5) | 0.1107 |
Local GH experiences | 29 (19.2) | 30 (26.3) | 0.1683 | 14 (9.3) | 15 (13.2) | 0.3157 | 25 (16.6) | 25 (21.9) | 0.2683 | 11 (7.3) | 14 (12.3) | 0.1683 |
Domestic/national GH experiences | 34 (22.5) | 24 (21.1) | 0.7754 | 13 (8.6) | 16 (14.0) | 0.1613 | 24 (15.9) | 23 (20.2) | 0.3663 | 9 (6.0) | 14 (12.3) | 0.0704 |
International GH experiences | 48 (31.8) | 18 (15.8) | 0.0029** | 20 (13.3) | 12 (10.5) | 0.5013 | 31 (20.5) | 20 (17.5) | 0.5416 | 12 (8.0) | 14 (12.3) | 0.2403 |
Hosting of GH participants from outside organization | 34 (22.5) | 22 (19.3) | 0.5252 | 13 (8.6) | 8 (7.0) | 0.6348 | 16 (10.6) | 15 (13.2) | 0.5206 | 8 (5.3) | 12 (10.5) | 0.1107 |
Collaborative GH activities | ||||||||||||
Collaborative GH education sessions | 31 (20.5) | 17 (14.9) | 0.2398 | 21 (13.9) | 12 (10.5) | 0.4092 | 30 (19.9) | 21 (18.4) | 0.7674 | 14 (9.3) | 11 (9.7) | 0.9171 |
Collaborative ward, clinical, or laboratory rounds | 21 (13.9) | 12 (10.5) | 0.4092 | 9 (6.0) | 8 (7.0) | 0.728 | 8 (5.3) | 9 (7.9) | 0.393 | 4 (2.7) | 10 (8.8) | 0.0485* |
Collaborative clinical case support activities | 18 (11.9) | 17 (14.9) | 0.4764 | 8 (5.3) | 13 (11.4) | 0.0685 | 13 (8.6) | 18 (15.8) | 0.0718 | 5 (3.3) | 11 (9.7) | 0.0320* |
Collaborative research activities | 25 (16.6) | 15 (13.2) | 0.4442 | 9 (6.0) | 11 (9.7) | 0.2604 | 16 (10.6) | 21 (18.4) | 0.0688 | 3 (2.0) | 13 (11.4) | 0.0028** |
Access to GH professional development | ||||||||||||
GH mentorship | 27 (17.9) | 19 (16.7) | 0.7961 | 14 (9.3) | 13 (11.4) | 0.57 | 22 (14.6) | 19 (16.7) | 0.6402 | 9 (6.0) | 13 (11.4) | 0.1118 |
Academic recognition for GH activities | 23 (15.2) | 15 (13.2) | 0.6334 | 11 (7.3) | 8 (7.0) | 0.9335 | 24 (15.9) | 18 (15.8) | 0.9816 | 7 (4.6) | 9 (7.9) | 0.2701 |
GH networking activities | 42 (27.8) | 22 (19.3) | 0.1088 | 24 (15.9) | 13 (11.4) | 0.2964 | 36 (23.8) | 22 (19.3) | 0.3759 | 11 (7.3) | 14 (12.3) | 0.1683 |